Patients with higher cholesterol levels showed improved survival outcomes (log-rank, p = 0.00035), with an adjusted (age, gender, race, SOFA score within the first 24 hours, and Charlson comorbidity index) hazard ratio of 0.80 (95% CI: 0.67-0.95, p = 0.012) for high versus low cholesterol groups ( Fig
Statements Author contributions FC: Conceptualization, Funding acquisition, Resources, Visualization, Writing original draft
These technologies enable identification of de novo target interactions, optimization of drug combinations, and prediction of drug efficacy along with toxicity, which may eventually translate into more effective and safer therapies for AD and other complex diseases (Vrahatis et al., 2023)
BPC-157 has been investigated for its effects on angiogenesis, nitric oxide signaling, and growth factor receptor expression
Yes, commonly
The medium-term profile is favorable